188 related articles for article (PubMed ID: 11107922)
21. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
22. Anogenital premalignant and malignant tumors (including Buschke-Löwenstein tumors).
Grussendorf-Conen EI
Clin Dermatol; 1997; 15(3):377-88. PubMed ID: 9255444
[No Abstract] [Full Text] [Related]
23. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of anogenital warts and cancer.
Franco EL
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):597-623. PubMed ID: 8869948
[TBL] [Abstract][Full Text] [Related]
25. Determination of Oncogenic Human Papillomavirus (HPV) Genotypes in Anogenital Cancers in Myanmar.
Mu Mu Shwe ; Hlaing Myat Thu ; Khin Saw Aye ; Aye Aye Myint ; Mya Thida ; Khin Shwe Mar ; Khin Khin Oo ; Khin Sandar Aye ; Okada S; Kyaw Zin Thant
Acta Med Okayama; 2016; 70(2):103-10. PubMed ID: 27094835
[TBL] [Abstract][Full Text] [Related]
26. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study.
Guimerà N; Lloveras B; Lindeman J; Alemany L; van de Sandt M; Alejo M; Hernandez-Suarez G; Bravo IG; Molijn A; Jenkins D; Cubilla A; Muñoz N; de Sanjose S; Bosch FX; Quint W;
Am J Surg Pathol; 2013 Sep; 37(9):1299-310. PubMed ID: 24076770
[TBL] [Abstract][Full Text] [Related]
27. The epidemiology of human papillomavirus infection and cervical cancer.
Bosch FX; de Sanjosé S
Dis Markers; 2007; 23(4):213-27. PubMed ID: 17627057
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology: a tool for the study of human papillomavirus-related carcinogenesis.
Fisher SG
Intervirology; 1994; 37(3-4):215-25. PubMed ID: 7843932
[No Abstract] [Full Text] [Related]
29. [What should be known for the introduction of an HPV vaccine?].
Muñoz N; Jacquard AC
Presse Med; 2008 Oct; 37(10):1377-90. PubMed ID: 18786806
[TBL] [Abstract][Full Text] [Related]
30. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
Louchini R; Goggin P; Steben M
Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments.
Ferenczy A; Coutlée F; Franco E; Hankins C
CMAJ; 2003 Sep; 169(5):431-4. PubMed ID: 12952805
[TBL] [Abstract][Full Text] [Related]
32. HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines.
Maniar KP; Nayar R
Adv Anat Pathol; 2014 Sep; 21(5):341-58. PubMed ID: 25105936
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus update with a particular focus on cervical disease.
Garland SM
Pathology; 2002 Jun; 34(3):213-24. PubMed ID: 12109780
[TBL] [Abstract][Full Text] [Related]
34. Genital papillomavirus in Greek women with high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Labropoulou V; Diakomanolis E; Dailianas S; Kalpaktsoglou K; Rodolakis A; Beaudenon S; Kakkanas A; Mavromara P
J Med Virol; 1996 Jan; 48(1):80-7. PubMed ID: 8825715
[TBL] [Abstract][Full Text] [Related]
35. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
36. Low-risk human papillomavirus types 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract.
Turazza E; Lapeña A; Sprovieri O; Torres CP; Gurucharri C; Maciel A; Lema B; Grinstein S; Kahn T
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):271-6. PubMed ID: 9093144
[TBL] [Abstract][Full Text] [Related]
37. [Coexistence of VIN and vulvar invasive cancer with intraepithelial neoplasia and invasive carcinoma of the cervix and/or vagina, and HPV infection of the low female genital tract].
Adamek K; Szczudrawa A; Basta A
Ginekol Pol; 2003 Sep; 74(9):657-61. PubMed ID: 14674103
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
39. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
40. Human papillomaviruses and the genital tract: old virus, new developments.
Birley HD; Hart CA; Stacey SN
J Med Microbiol; 1995 Aug; 43(2):81-4. PubMed ID: 7629857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
